CNK (NYSE: CNK) shareholder plans 30,026-share Rule 144 stock sale

Rhea-AI Filing Summary

A shareholder of CNK has filed a Form 144 notice to sell 30,026 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of 736,237.52. The proposed sale is expected to occur around 12/10/2025. As context, 117,475,902 shares of the issuer’s common stock were outstanding.

The shares to be sold were acquired as compensation through restricted stock award vesting transactions from the issuer in 2024, including tranches of 22,082, 4,798, and 3,146 common shares, each paid via compensation on their respective vesting dates.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Madison Avenue - 10th Floor New York NY 10017	30026	736237.52	117475902	12/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/08/2024	RSA Vesting	Issuer			22082	11/08/2024	Compensation
Common	02/23/2024	RSA Vesting	Issuer			4798	02/23/2024	Compensation
Common	02/20/2024	RSA Vesting	Issuer			3146	02/20/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many CNK common shares are covered by this Form 144 notice?

The Form 144 covers the proposed sale of 30,026 shares of CNK common stock.

What is the aggregate market value of the CNK shares to be sold?

The 30,026 CNK common shares have an aggregate market value of 736,237.52 based on the figures in the notice.

On which exchange and around what date are the CNK shares expected to be sold?

The shares are planned to be sold on the NYSE, with an approximate sale date of 12/10/2025.

How were the CNK shares in this Form 144 originally acquired?

The shares were acquired from the issuer via restricted stock award (RSA) vesting transactions in 2024, treated as compensation.

What were the individual RSA vesting amounts for the CNK shares?

The notice lists three RSA vesting events: 22,082 shares on 11/08/2024, 4,798 shares on 02/23/2024, and 3,146 shares on 02/20/2024, each identified as compensation.

How many CNK common shares were outstanding at the time of the notice?

The filing reports 117,475,902 shares of CNK common stock outstanding as a baseline figure.